The Haematology Service at Royal Lancaster Infirmary and Furness General improves Time in Therapeutic Range (TTR) levels with INRstar anticoagulation management solution. TTR levels for their anticoagulation (AC) patients have vastly improved since implementing INRstar across the service in 2014.
INRstar analytics was commissioned at Surrey Pathology Services in June 2015 to support the community based anticoagulation service of North West Surrey Clinical Commissioning Group (CCG) across 14 treatment locations.
Westcliffe Medical Centre in Shipley is using advanced functionality from INRstar, to manage patients taking direct oral anticoagulants (DOACs). Under updated recommendations, NICE says that DOACs, should be offered where appropriate.
The Northern Devon Healthcare NHS Trust uses INRstar’s External Patient Lookup to search for, view and treat anticoagulation patients who are not normally managed by the Trust.
Leicester City Clinical Commissioning Group (CCG) has worked in partnership with INRstar, to develop an award winning analytics tool to improve patient outcomes and improve commissioning efficiencies to support the Quality, Innovation, Productivity and Prevention (QIPP) programme.
The Royal Wolverhampton NHS Trust is one of the largest acute providers in the West Midlands. With Cannock Chase Hospital joining the Trust in November 2014, a requirement was identified for a new ‘dose and post’ laboratory service for tests that had previously been performed by Stafford Hospital.
Marsh Medical Centre, a rural practice in Lincolnshire with around 6,100 patients, has been running a level 4 practice-based Local Enhanced Service for anticoagulation for around 8 years.
St George’s Hospital in London runs an anticoagulation service with around 2,100 active patients. The hospital uses INRstar as its clinical decision support system and benefits from its new functionality which supports direct oral anticoagulants (DOACs) and LMWH.